Back
ESC2025 Premium Access

Validation of the DOAC Score among patients on vitamin K antagonists

Session: Oral anticoagulation in atrial fibrillation: new insights
Topic: Oral Anticoagulation
Speaker: Doctor R. Aggarwal (Boston, US)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Rahul Aggarwal

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
0 follower

4 more presentations in this session

Prior anticoagulation experience, bleeding risk, and safety of factor XI inhibition in atrial fibrillation: an analysis of AZALEA-TIMI 71

Speaker: Doctor S. Patel (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

Factor XI inhibitors or direct oral anticoagulants in atrial fibrillation: an updated meta-analysis

Speaker: Doctor M. Galli (Rome, IT)

Access
Abstract
Slides
Like
Thumbnail

Renal function and factor XI inhibition in atrial fibrillation: a pre-specified analysis of AZALEA-TIMI 71

Speaker: Doctor S. Patel (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

Renal function and long-term outcomes in edoxaban-treated patients: A subanalysis from ETNA-AF Europe 4 years follow up

Speaker: Professor R. De Caterina (Pisa, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Oral anticoagulation in atrial fibrillation: new insights

Speakers: Doctor R. Aggarwal, Doctor S. Patel, Doctor M. Galli, Doctor S. Patel, Professor R. De Caterina
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources